These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 2330863)

  • 21. Electrophysiologic effects of AHR 10718 on isolated cardiac tissues.
    Damiano BP; Le Marec H; Rosen MR
    Eur J Pharmacol; 1985 Feb; 108(3):243-55. PubMed ID: 3838726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of electrophysiologic mechanisms for the antiarrhythmic actions of R 56865 in cardiac glycoside toxicity.
    Damiano BP; Stump GL; Yagel SK
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):415-28. PubMed ID: 1720842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency-dependent effects of several class I antiarrhythmic drugs on Vmax of action potential upstroke in canine cardiac Purkinje fibers.
    Varro A; Elharrar V; Surawicz B
    J Cardiovasc Pharmacol; 1985; 7(3):482-92. PubMed ID: 2410678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiological effects of dridocainide on isolated canine, guinea-pig and human cardiac tissues.
    Pankucsi C; Hegedüs M; Kovács A; Szénási G; Szemerédi K; Nánási PP
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):520-8. PubMed ID: 8751081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rate and concentration-dependent effects of UK-68,798, a potent new class III antiarrhythmic, on canine Purkinje fibre action potential duration and Vmax.
    Knilans TK; Lathrop DA; Nánási PP; Schwartz A; Varró A
    Br J Pharmacol; 1991 Jun; 103(2):1568-72. PubMed ID: 1884111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of the frequency- and voltage-dependent effects of quinidine when administered in combination with tocainide in canine Purkinje fibers.
    Valois M; Sasyniuk BI
    Circulation; 1987 Aug; 76(2):427-41. PubMed ID: 2440617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiologic effects of Org 7797, a new steroidal antiarrhythmic agent: comparison with class 1a, 1b, and 1c drugs.
    Winslow E; Martorana M; Bell P
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):205-12. PubMed ID: 2476592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac effects of cibenzoline.
    Dangman KH
    J Cardiovasc Pharmacol; 1984; 6(2):300-11. PubMed ID: 6200720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiological studies of penticainide (CM 7857), a new antiarrhythmic agent, in mammalian myocardium.
    Gautier P; Guiraudou P; Pezziardi F; Bertrand JP; Gagnol JP
    J Cardiovasc Pharmacol; 1987 May; 9(5):601-10. PubMed ID: 2439843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local anesthetic and negative chronotropic effects of diltiazem on canine cardiac Purkinje fibers.
    Dangman KH; Ziam S; Miura DS
    Am Heart J; 1989 Jun; 117(6):1271-7. PubMed ID: 2729055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiologic effects of a new antiarrhythmic agent, recainam, on isolated canine and rabbit myocardial fibers.
    Takikawa R; Kamiya K; Kato R; Singh BN
    J Am Coll Cardiol; 1988 Apr; 11(4):875-81. PubMed ID: 3351157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of molecular form of local anesthetic-type antiarrhythmic agents on reduction of the maximum upstroke velocity of canine cardiac Purkinje fibers.
    Gintant GA; Hoffman BF; Naylor RE
    Circ Res; 1983 Jun; 52(6):735-46. PubMed ID: 6305532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of CM7857, a derivative of disopyramide, on electrophysiologic properties of canine Purkinje fibers and inotropic properties of canine ventricular muscle.
    Endou K; Yamamoto H; Sato T; Nakata F
    J Cardiovasc Pharmacol; 1986; 8(3):507-13. PubMed ID: 2425165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic effects of ethmozin in cardiac Purkinje fibers: suppression of automaticity and abolition of triggering.
    Dangman KH; Hoffman BF
    J Pharmacol Exp Ther; 1983 Dec; 227(3):578-86. PubMed ID: 6317840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency- and voltage-dependent effects of disopyramide in canine Purkinje fibers.
    Flemming MA; Sasyniuk BI
    Can J Physiol Pharmacol; 1989 Jul; 67(7):710-21. PubMed ID: 2766102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiological actions of disopyramide phosphate on canine ventricular muscle and purkinje fibers.
    Kus T; Sasyniuk BI
    Circ Res; 1975 Dec; 37(6):844-54. PubMed ID: 1192576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiological actions of BRB-I-28 in canine myocardial tissues.
    Patterson E; Scherlag BJ; Berlin KD; Lazzara R
    J Pharmacol Exp Ther; 1991 Nov; 259(2):558-65. PubMed ID: 1941607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular electrophysiological effect of terikalant in the dog heart.
    Biliczki P; Acsai K; Virág L; Tálosi L; Jost N; Biliczki A; Papp JG; Varró A
    Eur J Pharmacol; 2005 Mar; 510(3):161-6. PubMed ID: 15763239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of propafenone on sinus nodal and ventricular automaticity: in vitro and in vivo correlation.
    Katoh T; Karagueuzian HS; Sugi K; Ohta M; Mandel WJ; Peter T
    Am Heart J; 1987 Apr; 113(4):941-52. PubMed ID: 3565244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
    Malfatto G; Zaza A; Forster M; Sodowick B; Danilo P; Rosen MR
    J Pharmacol Exp Ther; 1988 Aug; 246(2):419-26. PubMed ID: 3404440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.